Pembrolizumab in Patients With Leptomeningeal Disease

NCT03091478 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Patients With Leptomeningeal Disease

Interventions

DRUG: Pembrolizumab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]